Code details & principles for
Code | Description | Chapter/Sub-Chapter | Code Specific Guidance |
---|---|---|---|
M6582 | Transperineal template-guided biopsies of the prostate under image guidance | 12.5.0 Prostate |
CCSD Code (unacceptable combination) | Narrative (unacceptable combination) | Date Added |
---|---|---|
BT212 | Insertion of low dose rate radioactive agent (brachytherapy) into prostate tumour | 2014-06-19 |
BT213 | Planning, insertion and removal of high dose rate radioactive treatment (brachytherapy) into prostate tumour | 2020-07-13 |
BT214 | Planning and insertion of low dose rate radioactive treatment (brachytherapy) into prostate tumour | 2020-07-13 |
BT215 | Planning for insertion of low dose rate radioactive treatment (brachytherapy) into prostate tumour | 2020-12-03 |
BT222 | Insertion and removal of high dose rate radioactive agent (brachytherapy) into prostate tumour | 2014-06-17 |
M6580 | Endoscopic biopsy of prostate (including cystoscopy) | 2010-06-14 |
M6583 | Transperineal MRI - US fusion targeted prostate biopsy | 2015-07-01 |
M6584 | Transrectal MRI - US fusion targeted prostate biopsy | 2015-11-30 |
M7020 | Transrectal sextant needle biopsy of prostate with ultrasound guidance | 2014-06-19 |
M7030 | Limited/single core transrectal needle biopsy of prostate +/- ultrasound guidance | 2014-02-07 |
These coding principles set out how the authors intend that the codes and narratives within the CCSD Schedule are interpreted and used. The outputs are available to be used by all individual insurers and providers including CCSD and non-CCSD members. Please note that: